InvestorsHub Logo
Followers 6
Posts 1257
Boards Moderated 0
Alias Born 06/14/2009

Re: None

Friday, 05/20/2022 4:01:44 AM

Friday, May 20, 2022 4:01:44 AM

Post# of 3683
The results of the Helios clinical trial have just been released. Athersys partner Healios stroke results Simply remarkable: The benefits provided to the TREASURE patients by MultiStem treatment represent good recovery, are clinically meaningful and should result in substantial improvement in quality of life for many stroke patients,” commented David C. Hess, MD, Dean and Presidential Distinguished Chair of Neurology at the Medical College of Georgia at Augusta University, investigator and lead author of the MASTERS-1 trial. “The TREASURE study enrolled an elderly stroke population with a median age of 78 years, making these results even more remarkable. We are excited about the MASTERS-2 study and the potential to add a new, clinically meaningful treatment option to stroke clinicians and patients.”

https://finance.yahoo.com/news/athersys-announces-partner-healios-k-070000689.html